Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06010433 · ClinicalTrials.gov registry record

CERAMENT G Device Registry

A clinical trial of Diabetic Foot Osteomyelitis and Chronic Osteomyelitis, sponsored by Bonesupport AB.

Recruiting
Registry status
100
Enrollment target
3
Study locations

NCT06010433 is a study of Diabetic Foot Osteomyelitis and Chronic Osteomyelitis that is actively recruiting participants, run by Bonesupport AB. The registered enrollment target is 100 participants. The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06010433, a study of Diabetic Foot Osteomyelitis and Chronic Osteomyelitis, is actively recruiting participants, sponsored by Bonesupport AB.

RECRUITING
Registry status
100 participants
Enrollment target
3
Study locations

Study Summary

This is an Observational Device Registry Study of CERAMENT\|G in normal use in accordance with the IFU. It will run for a period of three years from enrolment of the first patient into the Study at each Site, before being subject to review. A Device Registry is a form of observational study that concerns the performance of a device in normal use. It is intended to collect data that is reflective of 'real world' device performance.

Interventions

  • DEVICE CERAMENT G

Study Locations (3)

California

  • North Park Podiatry - San Diego

North Carolina

  • OrthoCarolina - Charlotte

Ohio

  • University Hospitals Cleveland Medical Center - Cleveland

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-08-17
Est. Completion 2028-09-22

Sponsor

Bonesupport AB

3 total trials

What the Registry Record Tells You About NCT06010433

The ClinicalTrials.gov registry entry for NCT06010433 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bonesupport AB, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Diabetic Foot Osteomyelitis appearing as the primary indexed condition, and to 1 intervention - of which CERAMENT G is the first listed.

NCT06010433 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, North Carolina, Ohio.

Frequently Asked Questions

What is clinical trial NCT06010433 about?

NCT06010433 is a clinical study titled "CERAMENT G Device Registry". This is an Observational Device Registry Study of CERAMENT\|G in normal use in accordance with the IFU. It will run for a period of three years from enrolment of the first patient into the Study at each Site, before being subject to review. A Device Registry is a form of observational study that con...

What is the current status of trial NCT06010433?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2023-08-17. Estimated completion is 2028-09-22.

What conditions does trial NCT06010433 study?

This clinical trial studies the following conditions: Diabetic Foot Osteomyelitis, Chronic Osteomyelitis, Fracture Related Infection.

What interventions are being tested in trial NCT06010433?

The interventions under investigation include: CERAMENT G (DEVICE).

Who is sponsoring clinical trial NCT06010433?

This trial is sponsored by Bonesupport AB, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06010433 being conducted?

This trial has 3 study locations across California, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetic Foot Osteomyelitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.